NEW YORK – The Personalized Medicine Coalition said this week that the number of personalized medicines on the market in the US has more than doubled over the past four years.
According to the sixth edition of the organization's Personalized Medicine Report, the number of individualized medicines on the US market grew from 132 in 2016 to 286 in 2020, a 116 percent spike and the largest four-year increase since it began tracking this figure in 2008. In contrast, between 2012 and 2016 precision therapies grew only about 62 percent.